<p>Cumulative sample size in launched and published trials of 2009 H1N1 vaccines over time.</p
<p>Monthly distribution of total number of samples and influenza A positive samples detected by RT-P...
<p>Mean and Interquartile Range of Raw HbA1c Testing Rates in 2010, by Decile of Estimated Rates in ...
<p>Number of counts (sample) and cumulative percentage of seropositive (IgG) cases among the childre...
<p>Time from start to completion (A) and from completion to publication (B) for 2009 H1N1 vaccine tr...
<p>Time from start to publication for 2009 H1N1 vaccine trials overall (A) and according to sponsor ...
†<p>Subjects, sample size and sampling period refer to those after observing the peak incidence of H...
<p>A, Proportion of seropositive versus-negative subjects by birth decades. B, Cumulative geometric ...
<p>Crude and adjusted pandemic H1N1 vaccine effectiveness per age category: Primary analysis with ba...
<p>Numbers of doses of vaccine delivered by various deployment strategies over time.</p
<p>The H1N1 positive tests reported to the CDC in the United States from April 24, 2009 (week 17) to...
*<p>adjusted for number of different drugs prescribed and number of GP contacts in year before.</p
<p>The percentage of serum samples that were HAI positive per decade of birth were identified for (A...
<p>Number of individuals included in the study, influenza vaccinations, and outcomes for each study ...
<p>Proportion of pandemic (H1N1) 2009 monovalent vaccine doses administered, by age group and type o...
<p>Sampling period for serosurvey (November 16-December 4, 2009) shown relative to epidemic curve. D...
<p>Monthly distribution of total number of samples and influenza A positive samples detected by RT-P...
<p>Mean and Interquartile Range of Raw HbA1c Testing Rates in 2010, by Decile of Estimated Rates in ...
<p>Number of counts (sample) and cumulative percentage of seropositive (IgG) cases among the childre...
<p>Time from start to completion (A) and from completion to publication (B) for 2009 H1N1 vaccine tr...
<p>Time from start to publication for 2009 H1N1 vaccine trials overall (A) and according to sponsor ...
†<p>Subjects, sample size and sampling period refer to those after observing the peak incidence of H...
<p>A, Proportion of seropositive versus-negative subjects by birth decades. B, Cumulative geometric ...
<p>Crude and adjusted pandemic H1N1 vaccine effectiveness per age category: Primary analysis with ba...
<p>Numbers of doses of vaccine delivered by various deployment strategies over time.</p
<p>The H1N1 positive tests reported to the CDC in the United States from April 24, 2009 (week 17) to...
*<p>adjusted for number of different drugs prescribed and number of GP contacts in year before.</p
<p>The percentage of serum samples that were HAI positive per decade of birth were identified for (A...
<p>Number of individuals included in the study, influenza vaccinations, and outcomes for each study ...
<p>Proportion of pandemic (H1N1) 2009 monovalent vaccine doses administered, by age group and type o...
<p>Sampling period for serosurvey (November 16-December 4, 2009) shown relative to epidemic curve. D...
<p>Monthly distribution of total number of samples and influenza A positive samples detected by RT-P...
<p>Mean and Interquartile Range of Raw HbA1c Testing Rates in 2010, by Decile of Estimated Rates in ...
<p>Number of counts (sample) and cumulative percentage of seropositive (IgG) cases among the childre...
DOI
Add to ORKG